Simplex Trading, LLC Ac Immune Sa Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$2.66 - $4.87 $1,689 - $3,092	635 New	635 $1,000
Q3 2023 Nov 01, 2023	BUY	$2.77 - $3.38 $1,531 - $1,869	553 New	553 $1,000
Q4 2022 Feb 02, 2023	BUY	$1.72 - $3.12 $3,262 - $5,918	1,897 Added 88.69%	4,036 $8,000
Q3 2022 Nov 04, 2022	BUY	$2.4 - $3.64 $4,389 - $6,657	1,829 Added 590.0%	2,139 $6,000
Q2 2022 Aug 03, 2022	BUY	$2.35 - $4.47 $728 - $1,385	310 New	310 $1,000
Q1 2022 May 02, 2022	SELL	$3.5 - $5.16 $7,658 - $11,290	-2,188 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$4.83 - $7.56 $7,496 - $11,733	-1,552 Reduced 41.5%	2,188 $10,000
Q2 2021 Aug 12, 2021	SELL	$6.04 - $8.37 $23,495 - $32,559	-3,890 Reduced 50.98%	3,740 $29,000
Q1 2021 Apr 26, 2021	BUY	$5.32 - $8.96 $40,591 - $68,364	7,630 New	7,630 $58,000
Q4 2020 Feb 02, 2021	SELL	$4.47 - $5.58 $39,429 - $49,221	-8,821 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$4.78 - $9.06 $42,164 - $79,918	8,821 New	8,821 $0

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.